Finzati - Logo
BHC logo

Bausch Health Companies Inc.

BHC • Drug Manufacturers - Specialty & Generic
$6.56
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$2.48B
Growth
16.3%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 1.5%Positive free cash flow · 2.7Consistent free cash flow · 4/5Reasonable earnings multiple · 16.14Healthy liquidity · 1.47
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$6.56
Change0.00%
Shares Out378.10M
Market Cap$2.48B
Enterprise Value$2.45B
52W Range4.33 - 8.69
Beta0.42
P/E-2.29
P/S0.25
P/B-1.40
P/FCF1.64
EV/Sales0.25

Investment DNA

How strong this company looks for long-term investors

67
out of 100
Business Quality
Margins, moat, returns
62/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
43/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Stable or improving margins · 1.5%Positive free cash flow · 2.7Consistent free cash flow · 4/5Reasonable earnings multiple · 16.14Healthy liquidity · 1.47

Analyst view

Analyst sentiment and price target

BHC
Analyst sentiment
Based on 38 analyst votes · 2026-09-05
70/100
Bullish
Bullish
19
Hold
15
Bearish
4
Price Target
2026-07-31
Low
$8.00
Mean
$9.83
Median
$8.50
High
$16.00

Company Overview

IPO: 3/29/1994
Industry: Drug Manufacturers - Specialty & Generic
P/B i: -1.40
Debt / Equity i: -38.35
Operating Margin: 21.28%
Net Margin: 1.53%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: -38.35
Current Ratio: 1.47
Quick Ratio: 1.08
Status: Moderate

Insider Transactions

Recent executive and insider activity

Lenar Aimee J.
Transaction: 07/17/2026
SELL
Change
-5,260
Price
$4.83
Filing
07/20/2026
Type
SELL
Lenar Aimee J.
Transaction: 07/15/2026
SELL
Change
-23,395
Price
$4.89
Filing
07/17/2026
Type
SELL
LEE STEVEN HYOSIG
Transaction: 07/14/2026
SELL
Change
-3,125
Price
$4.75
Filing
07/15/2026
Type
SELL